Zura Bio Ltd Reports Q2 2026 Financial Results, Updates Presentation

What Happened

• On August 11, 2026, Zura Bio Limited (ZURA) announced its second quarter 2026 financial results via a press release furnished as Exhibit 99.1 to an 8-K (Item 2.02).
• The company also provided an updated corporate presentation for upcoming investor meetings and conferences, filed as Exhibit 99.2 and posted in the “News & Events” section at investors.zurabio.com (Item 7.01).
• The report was signed on behalf of Zura Bio by Kim Davis, Chief Operating Officer, Chief Legal Officer and Corporate Secretary.

Key Details

• Filing date: August 11, 2026 (8-K covering Items 2.02 and 7.01).
• Press release (Exhibit 99.1) announces Q2 2026 results and is incorporated by reference in the 8-K.
• Updated corporate presentation (Exhibit 99.2) is Reg FD disclosure and available on the company’s investor website.
• Exhibits listed also include the Inline XBRL cover page (Exhibit 104).

Why It Matters

• Retail investors should review the press release and the updated presentation to see Zura Bio’s reported quarterly results, any changes to financial condition or guidance, and refreshed messaging about corporate strategy or milestones.
• The materials are the company’s official, timely disclosures for assessing near-term performance and any potential market reaction; the 8-K itself does not add new financial detail beyond furnishing those documents.